Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Present at May Conferences

WILMINGTON, Mass., Apr 25, 2005 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that management will present at two conferences in May 2005.

On Wednesday, May 11th, at 10:15 a.m. CDT, Chairman, President and Chief Executive Officer James C. Foster will present at the Baird 2005 Growth Stock Conference in Chicago.

On Wednesday, May 18th, at 10:00 a.m. PDT, Senior Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Banc of America Securities Health Care Conference in Las Vegas.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay for each conference will be accessible through the same website approximately three hours after the presentation and will remain available for one week from the date of the presentation.

SOURCE: Charles River Laboratories International, Inc.

Investor Relations Contact:
Charles River Laboratories International, Inc.
Susan E. Hardy, 978-658-6000 Ext. 1616
Director, Investor Relations

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)